title: Experience with new cyclosporine formulations: Consupren and Neoral in renal transplant patients.
authors.affiliation: Transplant Unit, Rizk Hospital, Beirut, Lebanon.
authors.forename: A
authors.initials: A
authors.lastname: Barbari
authors.forename: A
authors.initials: A
authors.lastname: Stephan
authors.forename: G
authors.initials: G
authors.lastname: Kamel
authors.forename: H
authors.initials: H
authors.lastname: Kilany
authors.forename: M A
authors.initials: MA
authors.lastname: Masri
mesh_terms: D000284:Administration, Oral; D000328:Adult; D002648:Child; D016572:Cyclosporine / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D004304:Dosage Forms; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics; D007408:Intestinal Absorption; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008657:Metabolic Clearance Rate; D013997:Time Factors
chemical_list: D004304:Dosage Forms; D007166:Immunosuppressive Agents; D016572:Cyclosporine